Poochmaxxing puts veterinary evidence to the test
Bottom line
The pet wellness boom is getting a new label: “poochmaxxing,” a trend described in a July 31, 2026, veterinary commentary as the extension of human-style optimization culture to dogs through specialty diets, supplements, physiotherapy, hydrotherapy, sports massage, wearable gear, and longevity-focused products. The idea is landing in a market with real momentum. APPA says U.S. pet industry spending reached $158 billion in 2025, with pet ownership holding at about 95 million U.S. households, underscoring how strongly pet parents are prioritizing health and quality of life for their animals. At the same time, the commentary and related coverage warn that marketing is moving faster than the evidence for many products and services, and that some clients may be tempted to substitute wellness purchases for primary veterinary care. (americanpetproducts.org)
Why it matters: For veterinary professionals, poochmaxxing is less about a buzzword than a case mix change. Clients are arriving with more supplements onboard, more questions about rehabilitation, nutrition, behavior, and aging, and more exposure to social media claims that can blur the line between supportive care and treatment. That matters in a regulatory environment where FDA says products intended to diagnose, cure, mitigate, treat, or prevent disease in animals may be unapproved animal drugs, and where animal dietary supplements do not have the same legal framework as human supplements. Evidence-based nutrition groups such as WSAVA and Tufts also continue to caution that attractive marketing claims often outpace proof, especially around supplements and raw diets. (fda.gov)
What to watch: Expect more demand for veterinary-led guidance on which wellness products belong in a care plan, which don’t, and where regulators draw the line on claims. (fda.gov)
“Poochmaxxing” is the latest shorthand for a familiar shift in companion animal care: pet parents are bringing human wellness habits, spending patterns, and optimization goals to their dogs. A July 31, 2026, veterinary commentary framed the trend as everything from physiotherapy and hydrotherapy to supplements, specialty nutrition, and recovery-oriented services, while warning that the commercial push around pet wellness is accelerating faster than the evidence base for many offerings. (the-independent.com)
The backdrop is a pet economy that keeps expanding. APPA says U.S. pet industry expenditures reached $158 billion in 2025, after $152 billion in 2024, and that pet ownership remained strong at roughly 95 million U.S. households. That growth is helping create space for premium and preventive categories, including calming products, mobility support, insurance, diagnostics, and nutrition add-ons. In other words, poochmaxxing is emerging in a market already primed to reward products that promise better health, longer life, or better daily function. (americanpetproducts.org)
What’s changed is not simply spending, but expectations. Coverage tied to the commentary describes pet parents applying the same “optimization instincts” they use in their own health routines to their animals. Veterinary Practice News has separately noted that supplement use has expanded dramatically over the past decade, with practitioners increasingly seeing patients on multiple products at once, often without clear therapeutic rationale or veterinary oversight. That creates a more complicated consult, especially when wellness purchasing is driven by targeted social media marketing rather than diagnosis. (the-independent.com)
There are legitimate parts of this ecosystem. Rehabilitation, pain management, nutrition counseling, and behavior support can all improve outcomes when used appropriately and under veterinary direction. But the concern raised in both the commentary and broader reporting is that the same market also rewards vague claims, anecdote-driven decision-making, and products that sit in a gray zone between food, supplement, and drug. FDA says animal products intended to diagnose, cure, mitigate, treat, or prevent disease can be considered unapproved animal drugs if they lack legal marketing status. The agency also notes that the human dietary supplement framework created by DSHEA does not apply to animal food products. (fda.gov)
Independent expert guidance points in the same direction. WSAVA’s Global Nutrition Guidelines emphasize that veterinary teams should be the evidence-based source of nutrition advice in a landscape crowded with confusing online information. Tufts nutrition resources likewise warn that “too good to be true” marketing, unverifiable claims, and ingredient theater are red flags, and note that many supplements have questionable safety, quality control, or effectiveness. Tufts also states that there is currently no evidence that raw diets provide benefits over cooked diets, despite persistent consumer interest. (wsava.org)
There’s also a clinical reason this matters now. As preventive and longevity messaging expands, veterinary teams may need to redirect clients toward fundamentals that still have the strongest evidence: complete and balanced nutrition, weight management, vaccination, parasite prevention, dental care, mobility assessment, and behavior screening. That last point may be especially relevant as wellness marketing leans heavily on stress and emotional health. A 2026 study highlighted by Texas A&M found that more than 84% of dogs showed at least mild signs of fear or anxiety in everyday situations, suggesting that behavior concerns are common, but also that they require proper assessment rather than retail solutions alone. (wsava.org)
Why it matters: For veterinary professionals, poochmaxxing is a business story, a communication story, and a standard-of-care story at once. It may expand demand for nutrition consults, rehabilitation, senior care, and behavior services, but it also increases the burden on clinicians to sort evidence from branding, identify interactions among multiple supplements, and keep clients from delaying diagnosis while trying trend-driven alternatives. Practices that can explain where supportive wellness fits, where it doesn’t, and why veterinary oversight matters may be better positioned to build trust with increasingly proactive pet parents. (veterinarypracticenews.com)
What to watch: The next phase is likely to be less about whether the pet wellness category grows and more about who defines it. Watch for more veterinary media scrutiny of supplement claims, more FDA attention to products that cross into drug territory, and more practices formalizing protocols for reviewing diets, supplements, and adjunctive therapies during routine visits. (fda.gov)